Several preclinical studies demonstrated anxiety-related behavioral abnormalities and cognitive impairments associated with conditional G9a/GLP deficiency and pharmacological inhibition of G9a activity in the brain (Schaefer et al., 2009; Wang et al., 2018). This evidence concerns the gene EHMT2 and Cognitive impairment.